$TRTC Recent Headlines 10-Q: TERRA TECH CORP. 4:31 p.m.

A New Chapter in GAC's European Journey GAC isn’t tiptoeing into Europe; the Chinese automaker hit the ground running with the launch of its AION UT and AION V in Italy. This isn't just another car release. Oh no, it’s GAC's grand entrance into a market saturated with well-established players. On October 8th, amidst the artistic vibes of Milan’s Superstudio Più,...

A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...

Berney Flowers: A Voice for Fiscal Change Oh boy, Berney Flowers sure isn't holding back. The Maryland congressional candidate is out here on Biz Talk Today TV, aiming straight at the heart of government waste and promising fiscal reform with the kind of intensity you don't see every day. Through the airwaves, he's been championing independent audits to keep those...

You know, sometimes it feels like the financial world gets more tangled than a fishing line on a windy beach. This latest spiel coming out of St. Croix with all its big names and lofty promises—Governor Bryan’s 3rd Wall Street Financial District Hub Initiative—seems like one of those, but maybe it’s got more meat than hype. Half the pitch sounds like your typical...

Doors Not Fully Open for Vet Technicians Here's the skinny: the vet industry’s sitting on a goldmine of untapped potential right under its nose. According to a fresh study by Penn Foster, there's a glaring disconnect between what vet techs are trained to handle and what they're actually allowed to do in practice. If practices start trusting these pros to do their thing,...

Indegene's AI Revolution in Pharma There's a new player making noise on the pharma playground, and it's called Indegene. This company just snagged the 2026 Global Enabling Technology Leadership Recognition from Frost & Sullivan for shaking up pharmaceutical commercialization with its cutting-edge AI arsenal. No fluff here—just a straight dive into how they're turning...

Teaching Kids to Catch Themselves: Introducing BEFORE Calling October Bullying Prevention Month seems quaint when you consider how often kids get shoved around, physically or emotionally. What’s surprising is how one simple word, ‘BEFORE,’ might just be the game-changer. Dr. Anke Otto-Wolf is betting big on it by unveiling the BEFORE Framework™. Imagine kids...

A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...

Ground Broken for Hard Rock Casino Tejon's Ambitious Expansion Who’s got a shovel ready? Hard Rock Casino Tejon does, kicking off a $725 million expansion that's turning heads all the way from Bakersfield to Los Angeles. Let's get something straight: this ain’t just another face-lift. We’re talking about a full-on transformation of the place into a plush resort...

Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...

Analyzing Atlassian's Options Activity Recently, significant activity has been noted in the options market for Atlassian (NASDAQ: TEAM), suggesting fluctuating sentiment among investors. With several key trades occurring, it is vital to understand the underlying forces driving these changes. Insights from Options Trading An examination of options history indicates that a...

Oncolytics Biotech's Strategic Move to Lead Cancer Innovation In a time where the global oncology drug market is projected to exceed an astounding $900 billion, interest in cancer-focused biotechnology companies has surged significantly. Analysts highlight the increasing demand for innovative diagnostics and advanced immunotherapies driving this growth. Yet, as these...

Changes in Leadership at Admirals Group AS Admirals Group AS recently held a significant general meeting where key changes to its management and supervisory boards were decided. Effective from a stated future date, Anton Tikhomirov and Fedor Ragin have been appointed to the supervisory board for a term of five years. This shift marks an exciting new chapter in the...

Athens Stock Market Performance Overview The latest updates reveal that Greece's stock market has closed on a positive note, showcasing notable increases across various sectors. The Athens General Composite Index has gained traction, finishing higher as key market sectors, particularly Construction, Travel, and Banking, experienced substantial growth. Sectorwise...

Introduction to Tremfya and Crohn's Disease Tremfya, a medication developed by Johnson & Johnson, has gained notable attention for its role in treating Crohn's disease. Recently, new results from its Phase 3 GRAVITI study have sparked interest in its potential expanded usage, showing promising outcomes for patients. Exciting Results from the GRAVITI Study The GRAVITI...